Selection of surrogate endpoint biomarkers to evaluate the efficacy of lycopene/tomatoes for the prevention/progression of prostate cancer

被引：8

作者：

Bowen, PE ^{[1
]}

机构：

[1] Univ Illinois, Dept Human Nutr, Chicago, IL 60612 USA

来源：

JOURNAL OF NUTRITION | 2005年 / 135卷 / 08期

关键词：

lycopene; tomatoes; biomarkers; prevention; prostate cancer;

D O I：

10.1093/jn/135.8.2068S

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

引用

页码：2068S / 2070S

页数：3

共 26 条

[1] Minimal debridement or simple wound closure as the only surgical treatment in war victims with low-velocity penetrating head injuries - Indications and management protocol based upon more than 8 years follow-up of 99 cases from Iran-Iraq conflict [J].

Amirjamshidi, A ;

Abbassioun, K ;

Rahmat, H ;

Hunt, CD .

SURGICAL NEUROLOGY, 2003, 60 (02) :105-111

[2] Lycopene and the lung [J].

Arab, L ;

Steck-Scott, S ;

Fleishauer, AT .

EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (10) :894-899

[3] Effects of supplementing a low-carotenoid diet with a tomato extract for 2 weeks on endogenous levels of DNA single strand breaks and immune functions in healthy non-smokers and smokers [J].

Briviba, K ;

Kulling, SE ;

Möseneder, J ;

Watzl, B ;

Rechkemmer, G ;

Bub, A .

CARCINOGENESIS, 2004, 25 (12) :2373-2378

[4] Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity [J].

Brusselmans, K ;

Vrolix, R ;

Verhoeven, G ;

Swinnen, JV .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (07) :5636-5645

[5]

Chan JM, 2002, J NATL CANCER I, V94, P1099

[6] Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention [J].

Chen, LW ;

Stacewicz-Sapuntzakis, M ;

Duncan, C ;

Sharifi, R ;

Ghosh, L ;

van Breemen, R ;

Ashton, D ;

Bowen, PE .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (24) :1872-1879

[7] Urinary 8-hydroxydeoxyguano sine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers [J].

Chiou, CC ;

Chang, PY ;

Chan, EC ;

Wu, TL ;

Tsao, KC ;

Wu, JT .

CLINICA CHIMICA ACTA, 2003, 334 (1-2) :87-94

[8] Insulin-like growth factors and risk of benign prostatic hyperplasia [J].

Chokkalingam, AP ;

Gao, YT ;

Deng, J ;

Stanczyk, FZ ;

Sesterhenn, IA ;

Mostofi, FK ;

Fraumeni, JF ;

Hsing, AW .

PROSTATE, 2002, 52 (02) :98-105

[9] New concepts in the pathology of prostatic epithelial carcinogenesis [J].

De Marzo, AM ;

Putzi, MJ ;

Nelson, WG .

UROLOGY, 2001, 57 (4A) :103-114

[10] Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate [J].

Herzog, A ;

Siler, U ;

Spitzer, V ;

Seifert, N ;

Denelavas, A ;

Hunziker, PB ;

Hunziker, W ;

Goralczyk, R ;

Wertz, K .

FASEB JOURNAL, 2004, 18 (14) :272-+

← 1 2 3 →